Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Cervical cancer screening task: ASCCP

Epigenetic modification: Biomarker for prognosis of pancreatic cancer

An Overview on Neutralizing Antibodies

Cervical cancer screening task: ASCCP
  • BiotechToday
  • World

Cervical cancer screening task: ASCCP

bioxone August 2, 2021August 1, 2021

Ananya Ghosal, MAKAUT(WB)

Guidelines of ASCCP

The American cancer society (ASC) released the screening guideline for cervical cancer. The guideline initiates a shift in practice to Human papilloma Virus (HPV) screening at the age of 25-65 years in people with the cervix. The American Society for colposcopy and cervical pathology (ASCCP) acknowledges the risk and benefits of HPV cervical cancer screening which recognizes the barriers to extensive implementation issues, adoption, the effect of limited HPV vaccination, and underrepresented minorities.

ASCCP initiates cervical cancer screening for secondary prevention of cervical cancer and improving the screening process for unscreened and under-screened. HPV test doesn’t only anticipate the current disease but also predicts the future disease. By extending the screening interval for 3-5 years the risk increases of human Papillomavirus (hrHPV) testing. Cytology provides the current picture of the disease. Two types of HPV tests are provided by the Food and Drug Administration (FDA), which are Cobas HPV and BD Onclarity HPV. Beginning the screening process in people at the age of 25years with average risk Cervix. The ASCCP acknowledges the importance of the change primary HPV screening and recognizing logistical considerations. Self-sampling is approved by FDA.

Practical issues with adoption of HPV screening

ASCCP expects is to gain full access to primary HPV testing. They operationalize the screening strategy in private and public laboratories, need to allocate funds for human resources and capital expenses to acquire new equipment and adopt workflow. Community-based health centers, private offices, and health care systems need to cooperate with the laboratories to execute HPV primary screening with new codes to use cytology as a reflex test.

The 2012 guideline stated increasing in the testing interval based on the presence or absence of HPV results and HPV co-testing. HPV testing and a combination of cytology were still included in the 2012 guideline. Due to the global pandemic, the financial challenges to healthcare have increased and left the healthcare system financially devastated. Due to the financial state, the cost of transition primary HPV screening on healthcare centers may not viable. To convert primary HPV testing for cervical cancer, the primary HPV testing should be a slow process, allowing making adequate changes. 

Effect of HPV vaccine

Secondary prevention has resulted in reduced deaths for cervical cancer by screening, detecting, and treatment. Most of the adults have not been vaccinated even when the vaccine was available. 21.5% of adults receive the advised number of doses and 39.9% of adults had received only one or more doses. The impact of immunization illustrated the reduction rate of cervical intraepithelial neoplasia grade 2.

Conclusion

The HPV vaccine improves and immunizes unit mature for screening age. To merge primary and secondary prevention, the transition to primary HPV screening programs and higher detection of CIN2+ has high immunization coverage in some countries than those adults screened at the age of 21years with cytology. The number of colposcopies to take one case CIN2+ has improved, that is, the ability to recognize the relevant disease. As per USPSTF guidelines, the ASCCP continued the acceptability of screening with cytology. The benefit of screening with cytology decreased and increasing harms, as the HPV immunization of the population, increased.

Also read: An intense embrace of two giants in cell division

Reference: Marcus, J. Z., Cason, P., Downs, L. S., Einstein, M. H., & Flowers, L. (2021). The ASCCP cervical cancer screening task force endorsement and opinion on the American cancer society updated cervical cancer screening guidelines. Journal of Lower Genital Tract Disease, 25(3), 187–191. https://doi.org/10.1097/LGT.0000000000000614

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged ASC ASCCP Cervical Cancer CIN2+ cytology FDA HPV immunization screening vaccination

One thought on “Cervical cancer screening task: ASCCP”

  1. Pingback: An Overview on Neutralizing Antibodies - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Biotechnopedia
  • DNA-Tales

An Overview on Neutralizing Antibodies

DNA tales August 2, 2021

Srabani Roy Chowdhury, MAKAUT, West Bengal Neutralizing antibodies are antibodies from the adaptive humoral immune system that neutralize a pathogen before entering our cells. And, they provide sterilizing immunity to our bodies by neutralizing the pathogen before infection. Production of these antibodies in our body happens naturally by our immune system. They are in charge […]

neutralizing antibodies

Related Post

  • BiotechToday
  • World

DENMARK TO KILL UPTO 17 MILLION MINKS!

bioxone November 8, 2020November 7, 2020

Aakancha Shaw, St. Xavier’s College, Kolkata Minks are dark-coloured and carnivorous mammals. Denmark has always been Europe’s largest producer and exporter of mink furs. So, Why is Denmark planning to kill its mink population? Recently, about 214 human COVID-19 cases in Denmark are related to minks. A mink-variant mutation in the spike protein of the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Use of semi-permeable capsules in multi-step processing of single cells

bioxone October 8, 2020October 7, 2020

Soumya Sarathi Ganguly, Indian Institute of Technology, Kharagpur Droplet microfluidic technologies can be used to isolate and process millions of single cells, but it fails to include molecular biology and cell-based phenotypic assays. Here, we can use a semi-permeable hydrogel capsule based on a microfluidic-based technique to simultaneously isolate and process millions of cells. The […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Hif1a gene in Microglia: A hope for Alzheimer’s patients

bioxone May 28, 2021May 28, 2021

Aakancha Shaw, St. Xavier’s College, Kolkata When we talk about the most common form of dementia Alzheimer’s Disease comes to our mind. This disease is characterized by the build-up of amyloid plaque in the brain. Microglia that are considered to be the immune Sentinels of the brain not only eliminate foreign invaders but are also […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy